Matching placebo
Matching placebo is a pharmaceutical drug with 322 clinical trials. Currently 44 active trials ongoing. Historical success rate of 84.8%.
Success Metrics
Based on 206 completed trials
Phase Distribution
Phase Distribution
97
Early Stage
116
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.7%
206 of 252 finished
18.3%
46 ended early
44
trials recruiting
322
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Clinical Trials (322)
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
The Therapeutic Effects of Ceylon Cinnamon Supplementation and a Self-Efficacy Educational Program on Glycemic Control, Lipid Profiles, and Pain in Type 2 Diabetes Mellitus With Painful Diabetic Peripheral Neuropathy
A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
Study of Single and Multiple Ascending Doses of KR23343 in Healthy Adult Participants
A Study of Barzolvolimab in Patients With Prurigo Nodularis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Perioperative Statins to Prevent AFib After Lung Surgery
HEALEY ALS Platform Trial - Regimen I NUZ-001
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 322